Ophthalmic Business

Top Story

Xephilio OCT-A1 receives 510(k) clearance

September 17, 2019

New technologies aimed at practitioner acceptance

September 15, 2019
PARIS — Technology has a purpose at Carl Zeiss Meditec and that is to function as a vehicle, not the driver, for delivering efficiency and better patient outcomes…

Alimera expands Iluvien distribution agreement with Horus

September 12, 2019
Alimera Sciences and Horus Pharma have expanded a distribution agreement to allow Horus to introduce Iluvien for diabetic macular edema and noninfectious posterior…

Wize Pharma licenses Copernicus’ gene therapy technology

September 10, 2019
Wize Pharma has entered into an exclusive license agreement to develop and commercialize products based on non-viral gene therapy technology from Copernicus…
More Headlines »
Original Article

Incidence and Risk Factors of Opaque Bubble Layer Formation According to Flap Thickness During 500-kHz FS-LASIK

Journal of Refractive Surgery, September 2019, Volume 35 Issue 9
To present the incidence, risk factors, and effect of opaque bubble layer (OBL) formation during flap creation in…
More »

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction…
More »
Meeting News

VIDEO: Take cues from patient questions to maximize advertising, communication

July 5, 2019
More »